Study Shows Horiba POC Analyzer Quickens Clinical Decisionmaking
The study found that using POC tests as a replacement for laboratory tests resulted in earlier decisionmaking in approximately 75% of cases across three UK hospital sites.
Read MorePosted by Steve Halasey | Jun 5, 2018 | Hematology Instrumentation, Molecular Diagnostics, POC Instruments, Research |
The study found that using POC tests as a replacement for laboratory tests resulted in earlier decisionmaking in approximately 75% of cases across three UK hospital sites.
Read MorePosted by Steve Halasey | Jun 5, 2018 | Hematology & Serology, Research, Transfusion & Transplantation Tests |
The research developed an optimized workflow for the recovery and culturing of CTCs from a simple blood test to produce an effective ex vivo culture of an individual patient’s cancer cells.
Read MorePosted by Elaine Sanchez Wilson | May 18, 2018 | Information Technology, Sepsis, Standards |
Beckman Coulter has exclusively sponsored the Escavo Sepsis Clinical Guide, a mobile, point-of-care medical reference application for healthcare professionals who manage septic patients in acute-care settings.
Read MorePosted by Elaine Sanchez Wilson | Apr 24, 2018 | Blood Banking, Hematology & Serology, Information Technology, Transfusion & Transplantation Tests |
The customizable middleware system centralizes laboratory operations and workflow across hospitals and networks, allowing blood banks and their data to be confidently managed through one central terminal.
Read MorePosted by Elaine Sanchez Wilson | Mar 21, 2018 | Breast |
FDA has expanded the approved use of Lynparza to include the treatment of patients with certain types of breast cancer that have spread and whose tumors have a specific inherited genetic mutation, making it the first drug in its class approved to treat breast cancer.
Read More